ICE
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ICE, covering 2020-03-11 to 2021-04-27. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymphoma [Phase 2]